Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma

Explore clinical trials studying Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma trial results

Completed

Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma

NCT02211131

Conditions: Completely Resectable Stage IIIB, IIIC, or IVM1a Melanoma
Locations: Research Site Birmingham, Alabama, United States

Research Site Duarte, California, United States

Research Site Orange, California, United States

Research Site San Francisco, California, United States

View all 46 locations

View Trial Details